A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome

OBJECTIVE: To explore the efficacy and safety of rituximab (RTX) in the treatment of autoimmune nephropathy manifested as refractory nephrotic syndrome (RNS). METHODS: A single-center prospective cohort study was conducted on RNS patients treated with RTX between March 2017 and December 2019. The su...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jing, Ding, Ying, Wan, Li, Yang, Qinghua, Qu, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Nephrology - Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732927/
https://www.ncbi.nlm.nih.gov/pubmed/33905043
http://dx.doi.org/10.1007/s11255-021-02860-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732927/
https://www.ncbi.nlm.nih.gov/pubmed/33905043
http://dx.doi.org/10.1007/s11255-021-02860-4

Ejemplares similares